Summary
Indicated for use in patients who were overweight (body mass index ≥ 27 kg/m2 with ≥ 1 comorbidities) or obese (body mass index ≥ 30 kg/m2) without diabetes mellitus, liraglutide has proven safe and effective in the SCALE–Obesity and Prediabetes trial. Combined with diet and exercise, liraglutide can improve weight and health-related quality-of-life factors.
- liraglutide
- weight loss
- weight management
- SCALE trial
- GLP-1
- waist circumference
- fasting plasma glucose
- © 2015 SAGE Publications
Tools
Liraglutide Leads to Increased Weight Loss Response in Patients Without Diabetes
Permalink:
Table of contents
Cited By...
- No citing articles found.